Boston Scientific has obtained CE mark for its EXALT Model B Single-Use Bronchoscope, a device meant for bedside procedures in the intensive care unit, operating room and bronchoscopy suite.
The company plans to introduce the bronchoscope soon, with a limited launch in Europe.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Designed especially for patients and procedures, EXALT Model B is equipped with suction and imaging capabilities.
The device will be marketed in slim, regular and large sizes to enable various bronchoscopy procedures, including secretion management, airway intubation, percutaneous tracheostomy, double-lumen endotracheal tube placement and biopsies.
Boston Scientific endoscopy president Dave Pierce said: “Single-use scopes are emerging as the preference for many physicians due to their ability to eliminate the risk of scope-related infection that may result from ineffective reprocessing while also increasing operational efficiencies in the hospital setting.
“Innovation is central to our mission, and the EXALT Model B Bronchoscope is designed to provide physicians with the high-quality functionality and feel of a reusable scope while addressing heightened patient safety needs and improving efficiency.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe latest asset in Boston Scientific’s single-use imaging portfolio, the bronchoscope is currently not offered in the US.
The company noted that approximately 1.5 million bronchoscope-based procedures are carried out in Europe every year.
Even though reprocessed reusable scopes are associated with a low risk of infection, some scope-related contaminations and post-procedure infections have been reported.
To fight this risk, the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology Nurses and Associates advise the usage of single-use endoscopic accessories if possible.
Last month, Boston Scientific reported net sales of $2.752bn in the first quarter, representing a growth of 8.2% on a reported basis, compared to $2.543bn in the same quarter last year.
